SSII Stock Forecast: SS Innovations International, Inc. Price Predictions for 2026-2027
The median 12-month analyst price target for SS Innovations International, Inc. is $2. Ticker Nerd's systematic factor model, run across ~4,300 US stocks, ranks it 11 of 100 as at 21 Nov 2026 — in the weakest quartile.
One number for the whole business
Consensus tells you what everyone already believes. The model scores SS Innovations International, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,300 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Quality (59): The business earns solid, repeatable profits on what it owns.
Momentum (7): The shares have been drifting down relative to others.
Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.
SSII stock forecast 2026-2027: analyst price targets & predictions
The bullish and bearish analyst opinions on SSII, reported as data — targets and ratings, the market's view beside the model's.
We don’t hold enough price history for this company yet.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 3 June 2026 | LUCID CAPITAL MARKETS | Initiates | Buy | $7.00 |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Wall Street targets run 12 to 18 months out. No analyst publishes a 2030 price target for SSII.
This page is one stock. Monday covers all of them.
SSII appears in the Radar on the weeks it earns a place.
- Market Radar, every Monday: the week's biggest rank moves across ~4,300 US stocks, and the reason for each.
- The AI build-out map, free: every AI company we track on one page, with the model's Top picks in all four parts.
AI cloud capacity
MSFTAMZNGOOGLORCL
AI chips
NVDAAVGOAMDMU
AI networking and servers
ANETDELLLITECRDO
Data centre power
VRTCEGGEVVST
SSII analyst estimate revisions
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
Financials
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
- Trailing P/E
- —
- Price / sales
- 5.6×
- Price / book
- 5.1×
- EV / EBITDA
- —
Cheaper than 19% of US stocks
Cheaper than 18% of US stocks
- Revenue growth (YoY)
- —
- Earnings growth (YoY)
- —
- Gross margin
- 50.9%
- Operating margin
- −27.7%
- Net margin
- —
Higher than 63% of US stocks
Higher than 21% of US stocks
- Return on equity
- −32.4%
- Return on assets
- −9.6%
- Dividend yield
- —
Higher than 27% of US stocks
Higher than 27% of US stocks
Bars mark the percentile across the ~4,300 US stocks Ticker Nerd covers, among those reporting the figure.
Key statistics
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
SS Innovations International, Inc. has a market value of $256.6M and an enterprise value of $269.8M.
Revenue in the twelve months to 30 June 2026: $52.4M. The latest quarter grew 39.4% year on year.
Net income over the same four quarters: −$12.4M, a −23.7% net margin.
Diluted earnings per share, trailing twelve months: −$0.06.
Free cash flow in the twelve months to 30 June 2026: −$18.2M.
SS Innovations International, Inc. employs 483 people — $108K of revenue per employee.
Data provided by Twelve Data
SSII and its peers
The nearest names by industry and size, scored by the same model — like for like.
Take a look at SSII’s peer groups, ranked by the model: healthcare stocks.
Look up any of the roughly 4,300 stocks we score.
The rank is the raw material. Whether the rules would actually own SS Innovations International, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
Questions about SSII
What is the SSII stock price forecast for 2026-2027?
The median 12-month analyst price target for SS Innovations International, Inc. is $2. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Is SSII stock a buy right now?
Of the 1 analyst covering SS Innovations International, Inc., 1 rate it a Buy, 0 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks SS Innovations International, Inc. 11 out of 100 across roughly 4,300 US stocks as at 21 Nov 2026. None of this is personal advice — it does not consider your circumstances.
How does Ticker Nerd's model rank SSII?
As at 21 Nov 2026, SS Innovations International, Inc. ranks 11 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,300 US stocks, built from its factor families. Its strongest factor family is Quality (59 of 100).
Will SSII stock go up?
No one can know that. What the data says: the median 12-month target from 1 analyst is $2, and Ticker Nerd's factor model ranks SS Innovations International, Inc. 11 out of 100 as at 21 Nov 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
What is the SSII stock forecast for 2030?
No analyst covering SS Innovations International, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for SSII are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $2 to $2 over the next 12 months.
What does SS Innovations International, Inc. do?
SS Innovations International, Inc. is a medical technology company focused on surgical robotics and related instruments. The company develops, manufactures, and commercializes robotic-assisted surgery systems designed to support minimally invasive procedures across multiple specialties, including cardiac, urology, gynecology, general surgery, and thoracic care.
About SS Innovations International, Inc.
SS Innovations International, Inc. is a medical technology company focused on surgical robotics and related instruments. The company develops, manufactures, and commercializes robotic-assisted surgery systems designed to support minimally invasive procedures across multiple specialties, including cardiac, urology, gynecology, general surgery, and thoracic care. Its product portfolio centers on the SSi Mantra surgical robotic system and the SSi Mudra line of surgical instruments, which together form an integrated platform for surgeons and hospitals. SS Innovations International serves healthcare providers in India and international markets, where its solutions are used to expand access to advanced robotic surgery and support a broad range of clinical applications. The company operates as a commercial-stage business within the medical devices and healthcare technology sectors.
CEO Dr. Sudhir Prem Srivastava M.D. · 483 employees · India · https://ssinnovations.com